RSV: Clinical Trials

1 trial for RSV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow RSV: new trials by email Literature Review of RSV trials Research Report on RSV

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
mRNA-1010, mRNA-1345, mRNA-1273.214 - SARS-CoV-2, Influenza
Phase 1CompletedModernaTX, Inc.3922022-10-142024-03-08

Narrower conditions

COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Influenza, Human (1)  ·  Virus Diseases (1)

Broader conditions

Coronaviridae Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Orthomyxoviridae Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

mRNA-1010 influenza vaccine (1)  ·  mRNA-1273.214 COVID-19 vaccine (1)  ·  mRNA-1345 respiratory syncytial virus vaccine (1)

Sponsors

ModernaTX, Inc. (1)

Countries

Australia (1)  ·  United Kingdom (1)  ·  United States (1)